(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Methylphenidate Hydrochloride: Oral capsule, biphasic release (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


CVS Pharmacy Patient Statistics for Methylphenidate Hydrochloride: Oral capsule, biphasic release(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Methylphenidate Hydrochloride CD 10mg Extended-Release Capsule

NDC: 621750151
  • Prescription Required
  • Federally Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Attention-deficit Hyperactivity Disorder (ADHD)

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Methylphenidate Hydrochloride CD 10mg Extended-Release Capsule
Drug Image file DrugItem_15743.JPG
Kremers Urban Inc. a Division of UCB, Inc.
Pill Identification: UCB 579 10 mg 
Shape: capsule
Color: green,white

Reported Side Effects for Methylphenidate Hydrochloride CD 10mg Extended-Release Capsule

Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Breakdown Of Muscle Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Lightheadedness Incidence:
<6.7%*
Severity: MILD
Onset: EARLY
Addiction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Neuroleptic Malignant Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Psychosis Incidence:
0.1%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
0.7-4.8%*
Severity: MODERATE
Onset: RAPID
Confusion Incidence:
1.2%*
Severity: MODERATE
Onset: EARLY
Emotional Lability Incidence:
1.4-9.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
1.4%*
Severity: MODERATE
Onset: DELAYED
Balance Problems Incidence:
1.7-2.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.7-10.2%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
>1.7%*
Severity: MODERATE
Onset: EARLY
Decreased Sexual Desire Incidence:
1.7%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
1.7%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Restlessness Incidence:
2.0-3.1%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
2.0-8.2%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
2.0-30.6%*
Severity: MILD
Onset: DELAYED
Distressed Incidence:
2.0-2.2%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
2.0-3.1%*
Severity: MODERATE
Onset: EARLY
Irritability Incidence:
2.0-11.0%*
Severity: MILD
Onset: DELAYED
Eye Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
2.0-2.2%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
2.0-16.6%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.2%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
>2.4%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
2.4-22.2%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.4-12.8%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
4.8-8.2%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
14.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Methylphenidate Hydrochloride CD 10mg Extended-Release Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Methylphenidate Hydrochloride CD 10mg Extended-Release Capsule(Methylphenidate Hydrochloride)
Alcohol and Methylphenidate Hydrochloride(Methylphenidate Hydrochloride)
Do not drink alcoholic beverages while taking certain forms of Methylphenidate. Side effects from Methylphenidate may get worse if you drink alcohol.
Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Methylphenidate Hydrochloride CD 10mg Extended-Release Capsule(Methylphenidate Hydrochloride)
Caffeine-containing Foods/Beverages and Methylphenidate Hydrochloride(Methylphenidate Hydrochloride)
Limit caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while taking Methylphenidate. Also avoid medicines containing additional Caffeine whenever possible. Side effects from Methylphenidate may get worse if you take excessive Caffeine. Taking a high amount of Caffeine can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, tremor, or other side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More